학술논문
Patient and caregiver experience with telepharmacy in cancer care to support beginning systemic therapy: A qualitative study.
Document Type
Article
Author
Source
Subject
*CANCER treatment
*PATIENT education
*HEALTH services accessibility
*QUALITATIVE research
*RESEARCH funding
*INTERVIEWING
*MEDICAL care
*DESCRIPTIVE statistics
*MEDICATION reconciliation
*TELEMEDICINE
*THEMATIC analysis
*CANCER chemotherapy
*COMBINED modality therapy
*RESEARCH methodology
*GROUNDED theory
*HOSPITAL pharmacies
*PATIENTS' attitudes
*CAREGIVER attitudes
*SPECIALTY hospitals
*CUSTOMER satisfaction
*DIET
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1078-1552
Abstract
Introduction: Although the COVID-19 pandemic spurred telehealth adoption for many specialties and care team roles, the patient and caregiver experience for telepharmacy visits has been relatively understudied. To our knowledge, there is a paucity of studies that have attempted to qualitatively evaluate this. This study aimed to qualitatively assess the patient and caregiver experience of telepharmacy visits in a cancer center. Methods: Semistructured interviews were conducted with 21 patients with cancer and seven caregivers that had attended a telepharmacy visit between December 1, 2021, and May 24, 2022. The interviews assessed visit content, overall satisfaction, system experience, visit quality, and future preferences for pharmacy visits as telehealth versus in-person. We used both deductive and inductive coding to identify themes. Results: Telepharmacy delivery was generally well-received. Reasons for having the telepharmacy visit included reviewing chemotherapy procedures, side effects to expect during treatment, providing education on recently prescribed medications, offering dietary recommendations (e.g., avoiding grapefruit juice), and performing medication reconciliation. Participants were receptive to having pharmacy visits through telehealth due to the perceived lack of a need to have a physical exam and prior relationship with the pharmacist. Participants also highlighted the main reason for the telepharmacy visits was primarily to provide patient education, which participants felt was suitable for telehealth. Conclusions: The patient and caregiver experience of telepharmacy is influenced by several factors, such as ease of connectivity, communicating effectively with the pharmacist, and timing of the telepharmacy visit (e.g., immediately after picking up medications from the pharmacy). Participants' recommendations to improve telepharmacy delivery included health systems raising awareness of telepharmacy services and providing a list of questions to patients to guide discussions. [ABSTRACT FROM AUTHOR]